Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Schizophrenia

  Free Subscription


19.08.2024

2 Acta Psychiatr Scand
1 J Clin Psychiatry
1 J Clin Psychopharmacol
1 J Psychiatry Neurosci
2 PLoS One
2 Proc Natl Acad Sci U S A
6 Psychiatry Res
4 Schizophr Res


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Psychiatr Scand

  1. LIN YP, Chen WY, Pan CH, Su SS, et al
    Age-stratified risk of suicide in patients with schizophrenia.
    Acta Psychiatr Scand. 2024 Aug 14. doi: 10.1111/acps.13747.
    PubMed         Abstract available

  2. AMBROSEN KS, Lemvigh CK, Nielsen MO, Glenthoj BY, et al
    Using computer vision of facial expressions to assess symptom domains and treatment response in antipsychotic-naive patients with first-episode psychosis.
    Acta Psychiatr Scand. 2024 Aug 12. doi: 10.1111/acps.13743.
    PubMed         Abstract available


    J Clin Psychiatry

  3. SOMMI RW, Saklad SR, Weiden PJ, Still D, et al
    Initiating Aripiprazole Lauroxil: Post Hoc Analysis of Safety and Tolerability of 1-Day and 21-Day Regimens.
    J Clin Psychiatry. 2024;85:23m15132.
    PubMed         Abstract available


    J Clin Psychopharmacol

  4. BUCHANAN RW, Werkheiser AE, Michel H, Zaranski J, et al
    Prebiotic Treatment in People With Schizophrenia.
    J Clin Psychopharmacol. 2024 Aug 16. doi: 10.1097/JCP.0000000000001899.
    PubMed         Abstract available


    J Psychiatry Neurosci

  5. ALONSO-SANCHEZ MF, Hinzen W, He R, Gati J, et al
    Perplexity of utterances in untreated first-episode psychosis: an ultra-high field MRI dynamic causal modelling study of the semantic network.
    J Psychiatry Neurosci. 2024;49:E252-E262.
    PubMed         Abstract available


    PLoS One

  6. BOSWORTH ML, Isles AR, Wilkinson LS, Humby T, et al
    Sex-dependent effects of Setd1a haploinsufficiency on development and adult behaviour.
    PLoS One. 2024;19:e0298717.
    PubMed         Abstract available

  7. HALLAJIAN AH, Sharifi K, Rostami R, Saeed F, et al
    Neurocognitive effects of 3 mA prefrontal electrical stimulation in schizophrenia: A randomized sham-controlled tDCS-fMRI study protocol.
    PLoS One. 2024;19:e0306422.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  8. WONG MMK, Sha Z, Lutje L, Kong XZ, et al
    The neocortical infrastructure for language involves region-specific patterns of laminar gene expression.
    Proc Natl Acad Sci U S A. 2024;121:e2401687121.
    PubMed         Abstract available

  9. MAKI-MARTTUNEN T, Blackwell KT, Akkouh I, Shadrin A, et al
    Genetic mechanisms for impaired synaptic plasticity in schizophrenia revealed by computational modeling.
    Proc Natl Acad Sci U S A. 2024;121:e2312511121.
    PubMed         Abstract available


    Psychiatry Res

  10. VITA A, Nibbio G, Barlati S
    Conceptualization and characterization of "primary" and "secondary" cognitive impairment in schizophrenia.
    Psychiatry Res. 2024;340:116126.
    PubMed         Abstract available

  11. GREVE AN, Hemager N, Mortensen EL, Gantriis DL, et al
    Comparing cognition in parents with schizophrenia or bipolar disorder and their 7-year-old offspring.
    Psychiatry Res. 2024;340:116112.
    PubMed         Abstract available

  12. DE HAAS HJ, Cohen D, de Koning MB, van Weringh G, et al
    Clozapine levels and outcomes in Serbian patients with treatment-resistant psychotic disorders previously treated without measuring clozapine levels (CLOSER).
    Psychiatry Res. 2024;339:116070.
    PubMed         Abstract available

  13. PICCHIONI M, Ruiz R, de Girolamo G, Iozzino L, et al
    The predictive validity and temporal characteristics of the HCR-20v3 for inpatient violence in forensic inpatient settings. An international study.
    Psychiatry Res. 2024;339:116079.
    PubMed         Abstract available

  14. ZACHOS KA, Choi J, Godin O, Chernega T, et al
    Mitochondrial Biomarkers and Metabolic Syndrome in Bipolar Disorder.
    Psychiatry Res. 2024;339:116063.
    PubMed         Abstract available

  15. LUYKX JJ, Tanskanen A, Lahteenvuo M, Manu P, et al
    Dopamine D2 receptor antagonism of antipsychotics and the risk of death due to choking.
    Psychiatry Res. 2024;339:116012.
    PubMed         Abstract available


    Schizophr Res

  16. LOCHMANN VAN BENNEKOM MWH, IntHout J, Gijsman HJ, Akdede BBK, et al
    Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data.
    Schizophr Res. 2024;272:1-11.
    PubMed         Abstract available

  17. MESSINIS A, Panteli E, Paraskevopoulou A, Zymarikopoulou AK, et al
    Altered lipidomics biosignatures in schizophrenia: A systematic review.
    Schizophr Res. 2024;271:380-390.
    PubMed         Abstract available

  18. PIRAS M, Popovic I, Ranjbar S, Grosu C, et al
    Aripiprazole dose associations with metabolic adverse effect: Results from a longitudinal study.
    Schizophr Res. 2024;270:403-409.
    PubMed         Abstract available

  19. KOHLER-FORSBERG O, Hojlund M, Rohde C, Kemp AF, et al
    Efficacy and acceptability of interventions to reduce antipsychotic polypharmacy: A systematic review and meta-analysis of randomized clinical trials.
    Schizophr Res. 2024;270:135-143.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.